Jafar Family Fund for Multiple Myeloma Research's Fundraising Page

Conquer cancer with the Jimmy Fund Walk!
Conquer Cancer with Dana-Farber and the Jimmy Fund!

WHY WE'RE FUNDRAISING WITH THE JIMMY FUND WALK TO FIGHT CANCER

The Jafar Family Fund for Multiple Myeloma Research at Dana-Farber Cancer Institute was established in 2017 to help accelerate research of new therapies for patients and families facing this disease. The fund is managed by Paul Richardson, MD, RJ Corman Professor of Medicine, Harvard Medical School, and Clinical Program Leader and Director of Clinical Research, Jerome Lipper Multiple Myeloma Center at Dana-Farber. All gifts to the Jafar Family Fund for Multiple Myeloma Research will help Dr. Richardson and his team lead clinical trials of promising therapies and support their tireless efforts to expand the arsenal of treatment options against this difficult disease.

PROGRESS TO GOAL

Raised:$54,260
Goal:$0
1team member

THANK YOU TO OUR TEAM MEMBERS

C = Team Captain
NAME
AMOUNT RAISED
x0x
x$54,260.00x

THANK YOU TO OUR TEAM DONORS

NAME
AMOUNT
Event Honor Roll
Gifts to Dana-Farber
$54,010
In memory of Gary Singer
$250
I'm Living Proof buttons
Every dollar raised helps fuel Dana-Farber Cancer Institute's mission.
Together, we can defy cancer!














My Giving Page

Conquer cancer with your Giving Page!

Jafar Family Fund for Multiple Myeloma Research

The Jafar Family Fund for Multiple Myeloma Research at Dana-Farber Cancer Institute was established in 2017 to help accelerate research of new therapies for patients and families facing this disease. The fund is managed by Paul Richardson, MD, RJ Corman Professor of Medicine, Harvard Medical School, and Clinical Program Leader and Director of Clinical Research, Jerome Lipper Multiple Myeloma Center at Dana-Farber. All gifts to the Jafar Family Fund for Multiple Myeloma Research will help Dr. Richardson and his team lead clinical trials of promising therapies and support their tireless efforts to expand the arsenal of treatment options against this difficult disease.

View More
View More